Aliglo 4x Growth Analysis Puts GC Pharma’s Q2-Q3 Sales Season in Focus

An analysis related to GC Pharma highlighted that Aliglo has grown fourfold. According to the headline reported by hankyung.com, the key point is Aliglo’s growth momentum and the fact that the second and third quarters are the peak season when sales are concentrated. Aliglo was cited as an important keyword in explaining GC Pharma’s performance, with attention on how sales may be weighted toward specific quarters. The provided source information does not include detailed revenue figures, the period used for the growth comparison, or other performance data. This article therefore focuses only on the stated facts: Aliglo’s fourfold growth and the Q2-Q3 peak sales season. Market attention is likely to remain on how concentrated Aliglo sales during that period are reflected in GC Pharma’s results. Source: hankyung.com